Peptide-Based Therapeutics in Cancer Therapy

Area of Science:

• Oncology
• Biochemistry
• Drug Discovery

Background:

• Cancer remains a leading global cause of death, with existing treatments facing challenges like high costs and adverse effects.
• Therapeutic peptides are emerging as a novel strategy for cancer treatment due to their unique advantages.
• Peptides offer flexibility, ease of modification, low immunogenicity, and cost-effective production compared to conventional therapies.

Purpose of the Study:

• To discuss the various types of therapeutic peptides utilized in cancer therapy.
• To highlight the benefits of therapeutic peptides, including targeted drug delivery and reduced toxicity.
• To explore the potential of peptides in developing cancer vaccines.

Main Methods:

• Review of current literature on therapeutic peptides for cancer.
• Categorization of peptides based on their application in cancer treatment (e.g., vaccines, tumor-targeting, cell-penetrating).
• Analysis of peptide characteristics relevant to cancer therapy, such as selectivity, specificity, and biocompatibility.

Main Results:

• Therapeutic peptides demonstrate high selectivity and specificity for cancer cells.
• Peptides offer advantages like small size, good biocompatibility, and ease of modification for targeted delivery.
• Peptides can be designed as antigens or adjuvants for effective cancer vaccine development.

Conclusions:

• Therapeutic peptides represent a novel and advantageous approach to cancer treatment.
• Peptide-based strategies, including tumor-targeting peptides (TTP) and cell-penetrating peptides (CPP), show significant promise.
• Further research into therapeutic peptides could lead to more effective and safer cancer therapies and vaccines.